August 17, 2017 12:03 PM ET

Biotechnology

Company Overview of Editas Medicine, Inc.

Executive Profile

Katrine S. Bosley

Chief Executive Officer, President and Director, Editas Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 8 different industries.

See Board Relationships
49$1,102,005
As of Fiscal Year 2016

Background

Ms. Katrine S. Bosley has been the Chief Executive Officer and President of Editas Medicine Inc. since June 24, 2014. Ms. Bosley served as the Chief Executive Officer at Celgene Avilomics Research, Inc. She served as Vice President of Business Development at Adnexus Therapeutics Inc. She served as Vice President of Strategic Operations at Adnexus Therapeutics Inc. since August 2004. She has been a leader in emerging companies with broad platforms for innovative medicines. ...

Corporate Headquarters

11 Hurley Street
Cambridge, Massachusetts 02142

United States

Phone: 617-401-9000
Fax: --

Board Members Memberships

2013-Present
Independent Non-Executive Director
2013-Present
Chairman
2014-Present
Chief Executive Officer, President and Director

Education

BA
Cornell University

Other Affiliations

Annual Compensation

Salary$450,000
Total Annual Compensation$450,000

Stocks Options

Unexercisable Options$38,461
Total Number of Options$38,461

Total Compensation

Total Annual Cash Compensation$672,750
Total Short Term Compensation$450,000
Total Calculated Compensation$1,102,005
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Alexander D. Macrae M.B., Ch.B, Ph.D., MRCPCEO, President & Director
Sangamo Therapeutics, Inc.
$697.0K
Rodger Novak M.D.Co-Founder, Chief Executive Officer and Director
CRISPR Therapeutics AG
$436.9K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Editas Medicine, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.